Clinical features of thyroid cancer in paediatric age. Experience of a tertiary centre in the 2000-2020 period

PurposeTo describe the clinical features of a paediatric cohort affected by differentiated thyroid cancer (DTC) followed in a tertiary Department of Paediatric Endocrinology.MethodsClinical data of 41 patients affected by DTC in the 2000-2020 period were reviewed.ResultsThe main risk factor was autoimmune thyroiditis (39%). Cytological categories were TIR3b in 39%, TIR4 in 9.8%, TIR5 in 51.2%. After total thyroidectomy, radioiodine treatment was performed in 38 subjects (92.7%). ATA low-risk category was assigned in 11 (30.5%), intermediate-risk category in 15 (41.7%), and high-risk category in 10 patients (27.8%). Age at diagnosis was 15.1 +/- 0.92 years in low-risk category, 14.7 +/- 0.59 in intermediate-risk category, 11.7 +/- 0.89 years in high-risk category (p = 0.01). TIR3b was manly observed in low-risk class (63.6%), while TIR5 was mainly reported in intermediate and high-risk class (60 and 80% respectively) (p = 0.04). Post-surgery stimulated thyroglobulin was increased in high-risk class (407.8 +/- 307.1 ng/ml) [p = 0.04]. Tumour size was larger in high-risk category (42.6 +/- 2.6 mm), than in low and intermediate-risk categories (19.4 +/- 3.5 mm and 28.5 +/- 3.9 mm, respectively) (p = 0.008). Patients in intermediate and high-risk categories displayed more tumour multifocality (60 and 90% respectively) (p < 0.005). Disease relapse was mainly observed in high risk category (40%, p = 0.04).ConclusionDTC in childhood is more aggressive than in adults, but the overall survival rate is excellent. The therapeutic approach is still heterogeneous, especially in low-risk category. Further studies are needed to standardise management and reduce disease persistence in childhood.